Luminex Q3 Net Loss Lowered on Valuation of Acquired Tm Assets

Nov 12, 2007

NEW YORK (GenomeWeb News) – Luminex said Friday that it has completed a preliminary valuation of acquired intangible assets related to its March acquisition of Tm Bioscience, which has since been renamed Luminex Molecular Diagnostics.

As a result of the updated valuation, Luminex lowered its third-quarter net loss to $1.9 million from the previously reported $3.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu